{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:17:38Z","timestamp":1776493058184,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,1,21]],"date-time":"2003-01-21T00:00:00Z","timestamp":1043107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,1,21]],"date-time":"2003-01-21T00:00:00Z","timestamp":1043107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1038\/sj.cgt.7700545","type":"journal-article","created":{"date-parts":[[2003,1,21]],"date-time":"2003-01-21T13:31:11Z","timestamp":1043155871000},"page":"134-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity"],"prefix":"10.1038","volume":"10","author":[{"given":"Yuji","family":"Tada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyang","family":"O-Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Sakiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,1,21]]},"reference":[{"key":"BF7700545_CR1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda T, Takahashi T, Goldstein P, et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993;75:1169\u20131178.","journal-title":"Cell."},{"key":"BF7700545_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0065-2776(08)60672-0","volume":"57","author":"S Nagata","year":"1994","unstructured":"Nagata S . Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1994;57:129\u2013144.","journal-title":"Adv Immunol."},{"key":"BF7700545_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1084\/jem.181.1.71","volume":"181","author":"MR Alderson","year":"1995","unstructured":"Alderson MR, Tough TW, Davis-Smith T, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med. 1995;181:71\u201377.","journal-title":"J Exp Med."},{"key":"BF7700545_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935\u2013946.","journal-title":"Cell."},{"key":"BF7700545_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994;76:969\u2013976.","journal-title":"Cell."},{"key":"BF7700545_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.7518614","volume":"265","author":"D Kagi","year":"1994","unstructured":"Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell\u2013mediated cytotoxicity. Science. 1994;265:528\u2013530.","journal-title":"Science."},{"key":"BF7700545_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/377630a0","volume":"377","author":"D Bellgrau","year":"1995","unstructured":"Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature. 1995;377:630\u2013632.","journal-title":"Nature."},{"key":"BF7700545_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand\u2013induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189\u20131192.","journal-title":"Science."},{"key":"BF7700545_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nm1296-1361","volume":"2","author":"S Strand","year":"1996","unstructured":"Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1\/Fas) ligand-expressing tumor cells \u2014 a mechanism of immune evasion?. Nat Med. 1996;2:1361\u20131366.","journal-title":"Nat Med."},{"key":"BF7700545_CR10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","volume":"274","author":"M Hahne","year":"1996","unstructured":"Hahne M, Rimoldi D, Schr\u00eeter M, et al. Melanoma cell expression of Fas (Apo-1\/CD95) ligand: implications for tumor immune escape. Science. 1996;274:1363\u20131366.","journal-title":"Science."},{"key":"BF7700545_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.184.3.1075","volume":"184","author":"J O'Connell","year":"1996","unstructured":"O'Connell J, O'Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med. 1996;184:1075\u20131082.","journal-title":"J Exp Med."},{"key":"BF7700545_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nm0297-165","volume":"3","author":"K Seino","year":"1997","unstructured":"Seino K, Kayagaki N, Okumura K, et al. Antitumor effect of locally produced CD95 ligand. Nat Med. 1997;3:165\u2013170.","journal-title":"Nat Med."},{"key":"BF7700545_CR13","doi-asserted-by":"publisher","first-page":"13862","DOI":"10.1073\/pnas.94.25.13862","volume":"94","author":"H Arai","year":"1997","unstructured":"Arai H, Gordon D, Nabel EG, et al. Gene transfer of Fas ligand induces tumor regression in vivo. Proc Natl Acad Sci USA. 1997;94:13862\u201313867.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BF7700545_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/sj.gt.3300763","volume":"5","author":"M Drozdzik","year":"1998","unstructured":"Drozdzik M, Qian C, Lasarte JJ, et al. Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL). Gene Ther. 1998;5:1622\u20131630.","journal-title":"Gene Ther."},{"key":"BF7700545_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/74955","volume":"6","author":"NP Restifo","year":"2000","unstructured":"Restifo NP . Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nat Med. 2000;6:493\u2013495.","journal-title":"Nat Med."},{"key":"BF7700545_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/85395","volume":"7","author":"J O'Connell","year":"2001","unstructured":"O'Connell J, Houston A, Bennett MW, et al. Immune privilege or inflammation? Insight into the Fas ligand enigma. Nat Med. 2001;7:271\u2013274.","journal-title":"Nat Med."},{"key":"BF7700545_CR17","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","volume":"282","author":"J-J Chen","year":"1998","unstructured":"Chen J-J, Sun Y, Nabel GJ . Regulation of the proinflammatory effects of Fas ligand (CD95L). Science. 1998;282:1714\u20131717.","journal-title":"Science."},{"key":"BF7700545_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1023\/A:1006632819086","volume":"17","author":"M Takasu","year":"1999","unstructured":"Takasu M, Tada J, Wang JO, et al. Resistance to apoptosis induced by microenvironmental stresses is correlated with metastatic potential in Lewis lung carcinoma. Clin Exp Metastasis. 1999;17:409\u2013416.","journal-title":"Clin Exp Metastasis."},{"key":"BF7700545_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1084\/jem.184.3.831","volume":"184","author":"J Wang","year":"1996","unstructured":"Wang J, Koizumi T, Watanabe T . Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in lyn-deficient mice. J Exp Med. 1996;184:831\u2013838.","journal-title":"J Exp Med."},{"key":"BF7700545_CR20","first-page":"61","volume":"75","author":"K Takenaga","year":"1984","unstructured":"Takenaga K . Characterization of low- and high-metastatic clones isolated from a Lewis lung carcinoma. Jpn J Cancer Res (Gann). 1984;75:61\u201371.","journal-title":"Jpn J Cancer Res (Gann)."},{"key":"BF7700545_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.191.3.423","volume":"191","author":"B Sauter","year":"2000","unstructured":"Sauter B, Albert ML, Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 2000;191:423\u2013433.","journal-title":"J Exp Med."},{"key":"BF7700545_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm0598-581","volume":"4","author":"A Melcher","year":"1998","unstructured":"Melcher A, Todryk S, Hardwick N, et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med. 1998;4:581\u2013587.","journal-title":"Nat Med."},{"key":"BF7700545_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/37022","volume":"390","author":"RE Voll","year":"1997","unstructured":"Voll RE, Herrmann M, Roth EA, et al. Immunosuppressive effects of apoptotic cells. Nature. 1997;390:350\u2013351.","journal-title":"Nature."},{"key":"BF7700545_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-\u03b2, PGE2 and PAF. J Clin Invest. 1998;101:890\u2013898.","journal-title":"J Clin Invest."},{"key":"BF7700545_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.163.1.130","volume":"163","author":"A Ronchetti","year":"1999","unstructured":"Ronchetti A, Rovere P, Iezzi G, et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol. 1999;163:130\u2013136.","journal-title":"J Immunol."},{"key":"BF7700545_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1084\/jem.187.10.1549","volume":"187","author":"WR Heath","year":"1998","unstructured":"Heath WR, Kurts C, Miller JFAP, et al. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med. 1998;187:1549\u20131553.","journal-title":"J Exp Med."},{"key":"BF7700545_CR27","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.4049\/jimmunol.162.8.4567","volume":"162","author":"F Geissmann","year":"1999","unstructured":"Geissmann F, Revy P, Regnault A, et al. TGF-\u03b21 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol. 1999;162:4567\u20134575.","journal-title":"J Immunol."}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700545","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T18:26:11Z","timestamp":1682447171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,21]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2,1]]}},"alternative-id":["BF7700545"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700545","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,21]]},"assertion":[{"value":"19 September 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2003","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}